Similar articles for PMID: 27517806

Year	Number of Results
1987	1
1996	1
1999	1
2000	1
2001	2
2002	3
2003	2
2004	3
2005	4
2006	1
2007	4
2008	5
2009	3
2010	8
2011	5
2012	8
2013	7
2014	4
2015	12
2016	10
2017	7
2018	3
2019	3
2020	7
2021	2
2022	4
2023	3
2024	0

1

Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer - A comprehensive review.

Polachi N, Bai G, Li T, Chu Y, Wang X, Li S, Gu N, Wu J, Li W, Zhang Y, Zhou S, Sun H, Liu C. Polachi N, et al. Eur J Med Chem. 2016 Nov 10;123:577-595. doi: 10.1016/j.ejmech.2016.07.070. Epub 2016 Jul 29. Eur J Med Chem. 2016. PMID: 27517806 Review.

2

Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy.

Bosch-Barrera J, Menendez JA. Bosch-Barrera J, et al. Cancer Treat Rev. 2015 Jun;41(6):540-6. doi: 10.1016/j.ctrv.2015.04.008. Epub 2015 Apr 27. Cancer Treat Rev. 2015. PMID: 25944486 Review.

3

Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.

Cufí S, Bonavia R, Vazquez-Martin A, Corominas-Faja B, Oliveras-Ferraros C, Cuyàs E, Martin-Castillo B, Barrajón-Catalán E, Visa J, Segura-Carretero A, Bosch-Barrera J, Joven J, Micol V, Menendez JA. Cufí S, et al. Food Chem Toxicol. 2013 Oct;60:360-8. doi: 10.1016/j.fct.2013.07.063. Epub 2013 Aug 1. Food Chem Toxicol. 2013. PMID: 23916468

4

Silibinin--a promising new treatment for cancer.

Cheung CW, Gibbons N, Johnson DW, Nicol DL. Cheung CW, et al. Anticancer Agents Med Chem. 2010 Mar;10(3):186-95. doi: 10.2174/1871520611009030186. Anticancer Agents Med Chem. 2010. PMID: 20015009 Review.

5

Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells.

Kauntz H, Bousserouel S, Gossé F, Raul F. Kauntz H, et al. Apoptosis. 2011 Oct;16(10):1042-53. doi: 10.1007/s10495-011-0631-z. Apoptosis. 2011. PMID: 21779837

6

Targeting silibinin in the antiproliferative pathway.

Li L, Zeng J, Gao Y, He D. Li L, et al. Expert Opin Investig Drugs. 2010 Feb;19(2):243-55. doi: 10.1517/13543780903533631. Expert Opin Investig Drugs. 2010. PMID: 20047507 Review.

7

New therapeutic potentials of milk thistle (Silybum marianum).

Milić N, Milosević N, Suvajdzić L, Zarkov M, Abenavoli L. Milić N, et al. Nat Prod Commun. 2013 Dec;8(12):1801-10. Nat Prod Commun. 2013. PMID: 24555302 Review.

8

Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer.

Fallah M, Davoodvandi A, Nikmanzar S, Aghili S, Mirazimi SMA, Aschner M, Rashidian A, Hamblin MR, Chamanara M, Naghsh N, Mirzaei H. Fallah M, et al. Biomed Pharmacother. 2021 Oct;142:112024. doi: 10.1016/j.biopha.2021.112024. Epub 2021 Aug 13. Biomed Pharmacother. 2021. PMID: 34399200 Free PMC article. Review.

9

Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art.

Di Costanzo A, Angelico R. Di Costanzo A, et al. Molecules. 2019 Jun 7;24(11):2155. doi: 10.3390/molecules24112155. Molecules. 2019. PMID: 31181687 Free PMC article. Review.

10

In vitro antimicrobial and modulatory activity of the natural products silymarin and silibinin.

de Oliveira DR, Tintino SR, Braga MF, Boligon AA, Athayde ML, Coutinho HD, de Menezes IR, Fachinetto R. de Oliveira DR, et al. Biomed Res Int. 2015;2015:292797. doi: 10.1155/2015/292797. Epub 2015 Mar 11. Biomed Res Int. 2015. PMID: 25866771 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year